Tokyo Metropolitan Government Plans Ivermectin Clinical Trials at City Hospitals

The Tokyo Metropolitan Government announced plans to conduct clinical trials investigating the use of Ivermectin at metropolitan and public hospitals to evaluate the anti-parasitic drug’s efficacy against SARS-CoV-2, the virus behind COVID-19. The studies will focus on patients with mild to serious symptoms and, interestingly, according to Nikkei Asia, they will not embark on finalizing the details of the study (e.g. duration, size, etc.) until “after the infection situation settles down.” This is interesting as cases spiked in November through early January and now appear to be on the decline. The spike in cases spooked health authorities. Clearly, if these accounts are correct the Metropolitan government responsible for the health and safety of nearly 40 million is thinking about alternative approaches to help take on this disease over the long run. TrialSite reported in mid 2020 that Tokyo’s Kitasato University would launch an ivermectin-based clinical trial. The man that discovered Ivermectin, Professor Satoshi Omura, taught there.

Nikkei Asia reports that the Metropolitan government seeks to use some of its beds at metropolitan and public hospitals...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee